(70 sec.) Drugmakers report mixed Q3 earnings, putting sector in focus.

Digital showcase produced by UK Trade & Investment, promoting the UK's expertise in Biotechnology and Pharmaceuticals. For more information on UK Trade & Investment and its...

When can we expect a turnaround for biotech stocks? MarketWatch’s Val Kennedy talks with industry experts about what lies ahead for the sector in these chilly economic times. (April 16)

Dr. Dinesh Patel describes himself humbly as a "big fish in a small pond." The managing director and founding partner of Salt Lake City-based vSpring Capital, he talks with us...

Digital showcase produced by UK Trade & Investment, promoting the uk's expertise in Biotechnology and Pharmaceuticals. For more information on UK Trade & Investment and its services please vis ...

Life scienes companies are always a punt, but there is a lot to be said for Verona Pharma here.This is not least because the diseases and disorders it wants to tackle are increasingly common.So let&ap ...

(270 sec.) A lackluster Q3 is no indication of slow growth at the biotech firm.

The latest trade on biotech, with CNBC's Mike Huckman. (CNBC) CNBC - Business - Biotechnology - Mike Huckman - Biotechnology and Pharmaceuticals

In midday trading Friday, the First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) is outperforming other ETFs, up about 3.6% on the day. Components of that ETF showing particular strength includ ...

H1N1 - Rodman & Renshaw, LLC - Part 3

The following video about why the North East of England is the location of choice for the Process industries (Biotechnology, Chemical, Renewables, Pharmaceuticals, Fine & Speciality, Polymer & ...

(NECN) - Vertex Pharmaceuticals, one of Cambridge's largest biotechnology companies, has committed to moving to Boston's new Fan Pier Development. Lisa Van Der pool joins us from the Boston ...

I will highlight 3 to 5 stocks a week off my Power_Scan and Bottom_Buster watch lists, so you guys can see the set ups before they make big moves.

H1N1 - Rodman & Renshaw, LLC - Part 2

French pharmaceutical company Sanofi-Aventis announced Monday it plans to grow its biotechnology unit, particularly in manufacturing capacity. Philippe Lanone, pharmaceutical analyst at Natixis, has m ...

Professor Stuart Connolly, co-principal investigator of the RE-LY study, McMaster University, Hamilton, Canada, explains the results of the RE-LY trial in achieving superior stroke reduction for atria ...

Christine Alan: Pharmaceutical Executive Search Kaye/Bassman Internal www.kbic.com (972) 931-5242 The Pharmaceutical & Biotechnology Specialty Practice has thrived for over 25 years, serving the c ...

(NECN) - A small Newton, Massachusetts-based biotechnology company may have a blockbuster lung cancer drug on its hands.  Novelos Pharmaceuticals is getting ready to release data on a ...

The markets may be down for the year, but biotech is faring better, with CNBC's Mike Huckman. (CNBC) CNBC - United States - Mike Huckman - Business - Biotechnology and...